查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1339231

基因組學市場中的人工智慧.份額.規模.趨勢.行業分析報告:按產品提供.技術.功能.應用.最終用戶.地區和細分市場的預測2023-2032 年

AI in Genomics Market Share, Size, Trends, Industry Analysis Report, By Offering (Software, Services), By Technology, By Functionality, By Application, By End User, By Region, Segment Forecast, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的一項新研究，到2032年，基因組學領域人工智慧的全球市場規模預計將達到167.5795億美元。該報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

產生基因組數據所需的大量財務支持在推動市場成長方面發揮關鍵作用。國家人類基因組研究所 (NHGRI) 等機構每年分配超過 1.25 億美元的大量資金來支持各種基因組數據科學計劃，為這一增長做出了重大貢獻。這種財政支持使研究人員和組織能夠創建和累積大量基因組數據集。隨著基因組數據量的增加，對人工智慧技術（包括機器學習和深度學習演算法）的需求不斷增長，以有效分析大量資訊並從中獲取見解。

私有雲和商業雲之間透過 STRIDES 等措施以及美國國立衛生研究院 (NIH) 等政府和公共機構之間的合作正在推動市場成長。這些聯合計劃將支援儲存和運算基礎設施來託管基因組數據。這些措施提供了一個可擴展且安全的平台，用於處理基因組研究中產生的大量基因組數據。此外，這些公司優先考慮實施強有力的安全和隱私措施，以保護敏感的人類基因組資料。

基因組學市場中的人工智慧報告亮點

由於基因組數據的增加，預計軟體產業在未來幾年將成長更快。

由於資料量和複雜性不斷增加，機器學習領域佔據了最大的收入份額。

由於 DNA 定序技術的進步，基因組定序領域預計將佔據最大的收入份額。

由於個人化治療方法的增加，精準醫學預計將出現強勁的成長。

由於藥物發現的加速，製藥和生物技術公司預計將顯著成長。

由於政府不斷採取措施促進醫療保健，預計北美將佔據最大的收入份額。另一方面，歐洲將透過資助計畫獲得政府的推動，預計將獲得更大的收入份額。

目錄

第 1 章 簡介

第二章執行摘要

第三章研究方法論

第 4 章：基因組學領域的全球人工智慧市場洞察

  • 基因組學中的人工智慧 - 產業快照
  • 基因組學領域的人工智慧市場動態
    • 驅動因素和機遇
      • 生物醫學研究計畫快速成長
      • 技術進步與運算能力
    • 限制因素和挑戰
      • 數據品質和可用性
  • PESTLE分析
  • 基因組學產業的人工智慧趨勢
  • COVID-19 感染的影響分析

第五章基因組學領域的全球人工智慧市場，透過提供

  • 主要發現
  • 介紹
  • 軟件
  • 服務

第六章 全球基因體學人工智慧市場（按技術）

  • 主要發現
  • 介紹
  • 機器學習
  • 其他技術

第七章 全球基因體學人工智慧市場（按功能）

  • 主要發現
  • 介紹
  • 基因組測序
  • 基因編輯
  • 臨床工作流程
  • 預測基因檢測與預防醫學

第八章全球基因組學人工智慧市場（按應用）

  • 主要發現
  • 介紹
  • 診斷
  • 藥物發現與開發
  • 精準醫學
  • 農業和動物研究
  • 其他用途

第 9 章 全球基因組學人工智慧市場（按最終用戶）

  • 主要發現
  • 介紹
  • 製藥和生物技術公司
  • 保健提供者
  • 研究中心、學術機構、政府機構
  • 其他最終用戶

第10章全球基因組學人工智慧市場（按地區）

  • 主要發現
  • 介紹
    • 基因組學人工智慧市場評估（按地區），2019-2032
  • 基因組學人工智慧市場 - 北美
    • 北美：2019-2032 年基因組學人工智慧市場（按產品分類）
    • 北美：基因組學人工智慧市場（按應用），2019-2032
    • 北美：基因組學人工智慧市場（按技術），2019-2032
    • 北美：基因組學人工智慧市場（按功能），2019-2032
    • 北美：基因組學人工智慧市場，按最終用戶劃分，2019-2032 年
    • 基因組學人工智慧市場 - 美國
    • 基因組學人工智慧市場 - 加拿大
  • 基因組學人工智慧市場 - 歐洲
    • 歐洲：基因組學人工智慧市場（按產品劃分），2019-2032 年
    • 歐洲：基因組學人工智慧市場（按應用），2019-2032 年
    • 歐洲：基因組學人工智慧市場（按技術），2019-2032
    • 歐洲：基因組學人工智慧市場（按功能），2019-2032
    • 歐洲：基因組學人工智慧市場，按最終用戶劃分，2019-2032 年
    • 基因組學人工智慧市場 - 英國
    • 基因組學人工智慧市場 - 法國
    • 基因組學人工智慧市場 - 德國
    • 基因組學人工智慧市場 - 義大利
    • 基因組學人工智慧市場 - 西班牙
    • 基因組學人工智慧市場 - 荷蘭
    • 基因組學人工智慧市場 - 俄羅斯
  • 基因組學人工智慧市場 - 亞太地區
    • 亞太地區：2019-2032 年基因體學人工智慧市場（依產品分類）
    • 亞太地區：基因組學人工智慧市場（按應用），2019-2032 年
    • 亞太地區：基因組學人工智慧市場（按技術），2019-2032 年
    • 亞太地區：基因組學人工智慧市場（按功能），2019-2032
    • 亞太地區：基因組學人工智慧市場，按最終用戶劃分，2019-2032 年
    • 基因組學人工智慧市場 - 中國
    • 基因組學人工智慧市場—印度
    • 基因組學領域的人工智慧市場——日本
    • 基因組學人工智慧市場 - 馬來西亞
    • 基因組學人工智慧市場 - 印度尼西亞
    • 基因組學人工智慧市場—韓國
  • 基因組學人工智慧市場 - 中東和非洲
    • 中東和非洲：基因組市場中的人工智慧（按產品劃分），2019-2032 年
    • 中東和非洲：基因組學人工智慧市場（按應用），2019-2032 年
    • 中東和非洲：基因組學人工智慧市場（按技術），2019-2032 年
    • 中東和非洲：基因組學人工智慧市場（按功能），2019-2032
    • 中東和非洲：基因組學人工智慧市場，按最終用戶劃分，2019-2032 年
    • 基因組學人工智慧市場 - 沙烏地阿拉伯
    • 基因組學人工智慧市場 - 阿聯酋
    • 基因組學人工智慧市場 - 以色列
    • 基因組學人工智慧市場 - 南非
  • 基因組學人工智慧市場 - 拉丁美洲
    • 拉丁美洲：2019-2032 年基因組學人工智慧市場（按產品分類）
    • 拉丁美洲：基因組學人工智慧市場（按應用），2019-2032 年
    • 拉丁美洲：基因組學人工智慧市場（按技術），2019-2032 年
    • 拉丁美洲：基因組學人工智慧市場（按功能），2019-2032 年
    • 拉丁美洲：基因組學人工智慧市場，按最終用戶劃分，2019-2032 年
    • 基因組學人工智慧市場 - 墨西哥
    • 基因組學人工智慧市場 - 巴西
    • 基因組學人工智慧市場 - 阿根廷

第十一章競爭格局

  • 擴張和收購分析
    • 擴張
    • 獲得
  • 夥伴關係/協作/協議/揭露

第十二章公司簡介

  • Google DeepMind
  • IBM Watson Health
  • BenevolentAI
  • Tempus
  • Freenome
  • Sophia Genetics
  • 23andMe
  • DNAnexus
  • Recursion Pharmaceuticals
  • Verge Genomics
  • PathAI
  • GNS Healthcare
  • Freenome
  • Fabric Genomics
  • Foundation Medicine
  • SOPHiA GENETICS
  • Nebula Genomics
  • CytoReason
  • Genoox
  • Genalice
  • Deep Genomics
  • Owkin
  • Genialis
  • Gencove
  • Helix
  • QIAGEN Bioinformatics
  • SOPHiA DDM
  • WuXi NextCODE
  • Genuity Science
  • Lifebit
  • Envisagenics
  • ZS Genetics
  • MedGenome
  • Cypher Genomics
  • PierianDx
  • Bluebee
  • Repositive
  • Precision for Medicine
  • Shivom
  • Bluegnome
Product Code: PM3611

The global AI in genomics market size is expected to reach USD 16,757.95 million by 2032, according to a new study by Polaris Market Research. The report "AI in Genomics Market Share, Size, Trends, Industry Analysis Report, By Offering (Software, Services), By Technology, By Functionality, By Application, By End User, By Region, Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The substantial financial support required to generate genomic data plays a crucial role in driving the market's growth. Institutions like the National Human Genome Research Institute (NHGRI) contribute significantly to this growth by allocating substantial funding, with an annual investment of over $125 million, to support diverse genomic data science initiatives. This financial backing enables researchers and organizations to generate and accumulate extensive genomic datasets. As the volume of genomic data increases, the demand for AI technologies, including machine learning and deep learning algorithms, rises to effectively analyze and derive insights from this vast amount of information.

The collaboration between private & commercial cloud and governmental & public entities, such as the National Institutes of Health (NIH) through initiatives like STRIDES, drives the market's growth. These collaborative initiatives support the storage and computing infrastructure to host genomic data. They provide scalable and secure platforms to handle the large volumes of genomic data generated in genomics research. Additionally, they prioritize implementing robust security and privacy measures to safeguard sensitive human genomic data.

AI in Genomics Market Report Highlights

Software segment is anticipated to witness faster growth in the coming years due to the rise in genomic data.

Machine Learning segment accounted for the largest revenue share owing to the increased volume and complexity of data.

Genome Sequencing segment is projected to experience the largest revenue share due to the advancements in DNA sequencing technologies.

Precision Medicine is expected to witness significant growth rate due to growing personalized treatment approaches.

Pharmaceuticals and Biotech Companies are expected to grow at a substantial rate due to accelerated drug discovery.

North America is projected to witness largest revenue share owing to the rise in government initiatives to promote healthcare. While Europe is expected to grow a larger revenue share owing to the encouragement from the governments by funding the projects.

The global players include: Google DeepMind, QIAGEN Bioinformatics, SOPHiA DDM, WuXi NextCODE, Genuity Science, Lifebit, Envisagenics, ZS Genetics, MedGenome, Cypher Genomics, PierianDx, Bluebee, Repositive, Precision for Medicine, Shivom & Bluegnome.

Polaris Market Research has segmented the AI in Genomics market report based on offering, technology, functionality, application, end user and region:

AI in Genomics, Offering Outlook (Revenue - USD Million, 2019 - 2032)

  • Software
  • Services

AI in Genomics, Technology Outlook (Revenue - USD Million, 2019 - 2032)

  • Machine Learning
  • Deep Learning
  • Supervised Learning
  • Unsupervised Learning
  • Reinforcement Learning
  • Other Machine Learning Technologies
  • Other Technologies

AI in Genomics, Functionality Outlook (Revenue - USD Million, 2019 - 2032)

  • Genome Sequencing
  • Gene Editing
  • Clinical Workflows
  • Predictive Genetic Testing & Preventive Medicine

AI in Genomics, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Diagnostics
  • Drug Discovery & Development
  • Precision Medicine
  • Agriculture & Animal Research
  • Other Applications

AI in Genomics, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceutical and Biotech Companies
  • Healthcare Providers
  • Research Centres, Academic Institutes and Government Organization
  • Other End Users

AI in Genomics, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global AI in Genomics Market Insights

  • 4.1. AI in Genomics - Industry Snapshot
  • 4.2. AI in Genomics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Exponential growth of biomedical research projects
      • 4.2.1.2. Technological advancements and computational power
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Data quality and availability
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. AI in Genomics Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global AI in Genomics Market, by Offering

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • 5.3. Software
    • 5.3.1. Global AI in Genomics Market, by Software, by Region, 2019-2032 (USD Million)
  • 5.4. Services
    • 5.4.1. Global AI in Genomics Market, by Services, by Region, 2019-2032 (USD Million)

6. Global AI in Genomics Market, by Technology

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • 6.3. Machine Learning
    • 6.3.1. Global AI in Genomics Market, by Machine Learning, by Region, 2019-2032 (USD Million)
    • 6.3.2. Deep Learning
      • 6.3.2.1. Global AI in Genomics Market, by Deep Learning, by Region, 2019-2032 (USD Million)
    • 6.3.3. Supervised Learning
      • 6.3.3.1. Global AI in Genomics Market, by Supervised Learning, by Region, 2019-2032 (USD Million)
    • 6.3.4. Unsupervised Learning
      • 6.3.4.1. Global AI in Genomics Market, by Unsupervised Learning, by Region, 2019-2032 (USD Million)
    • 6.3.5. Reinforcement Learning
      • 6.3.5.1. Global AI in Genomics Market, by Reinforcement Learning, by Region, 2019-2032 (USD Million)
    • 6.3.6. Other Machine Learning Technologies
      • 6.3.6.1. Global AI in Genomics Market, by Other Machine Learning Technologies, by Region, 2019-2032 (USD Million)
  • 6.4. Others Technologies
    • 6.4.1. Global AI in Genomics Market, by Others Technologies, by Region, 2019-2032 (USD Million)

7. Global AI in Genomics Market, by Functionality

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • 7.3. Genome Sequencing
    • 7.3.1. Global AI in Genomics Market, by Genome Sequencing, by Region, 2019-2032 (USD Million)
  • 7.4. Gene Editing
    • 7.4.1. Global AI in Genomics Market, by Gene Editing, by Region, 2019-2032 (USD Million)
  • 7.5. Clinical Workflows
    • 7.5.1. Global AI in Genomics Market, by Clinical Workflows, by Region, 2019-2032 (USD Million)
  • 7.6. Predictive Genetic Testing & Preventive Medicine
    • 7.6.1. Global AI in Genomics Market, by Predictive Genetic Testing & Preventive Medicine, by Region, 2019-2032 (USD Million)

8. Global AI in Genomics Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • 8.3. Diagnostics
    • 8.3.1. Global AI in Genomics Market, by Diagnostics, by Region, 2019-2032 (USD Million)
  • 8.4. Drug Discovery & Development
    • 8.4.1. Global AI in Genomics Market, by Drug Discovery & Development, by Region, 2019-2032 (USD Million)
  • 8.5. Precision Medicine
    • 8.5.1. Global AI in Genomics Market, by Precision Medicine, by Region, 2019-2032 (USD Million)
  • 8.6. Agriculture & Animal Research
    • 8.6.1. Global AI in Genomics Market, by Agriculture & Animal Research, by Region, 2019-2032 (USD Million)
  • 8.7. Other Applications
    • 8.7.1. Global AI in Genomics Market, by Other Applications, by Region, 2019-2032 (USD Million)

9. Global AI in Genomics Market, by End User

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • 9.3. Pharmaceutical and Biotech Companies
    • 9.3.1. Global AI in Genomics Market, by Pharmaceutical and Biotech Companies, by Region, 2019-2032 (USD Million)
  • 9.4. Healthcare Providers
    • 9.4.1. Global AI in Genomics Market, by Healthcare Providers, by Region, 2019-2032 (USD Million)
  • 9.5. Research Centres, Academic Institutes and Government Organization
    • 9.5.1. Global AI in Genomics Market, by Research Centres, Academic Institutes and Government Organization, by Region, 2019-2032 (USD Million)
  • 9.6. Other End Users
    • 9.6.1. Global AI in Genomics Market, by Other End Users, by Region, 2019-2032 (USD Million)

10. Global AI in Genomics Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. AI in Genomics Market Assessment, By Geography, 2019-2032 (USD Million)
  • 10.3. AI in Genomics Market - North America
    • 10.3.1. North America: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
    • 10.3.2. North America: AI in Genomics Market, by Application, 2019-2032 (USD Million)
    • 10.3.3. North America: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
    • 10.3.4. North America: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
    • 10.3.5. North America: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.3.6. AI in Genomics Market - U.S.
      • 10.3.6.1. U.S.: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.3.6.2. U.S.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.3.6.3. U.S.: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.3.6.4. U.S.: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.3.6.5. U.S.: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.3.7. AI in Genomics Market - Canada
      • 10.3.7.1. Canada: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.3.7.2. Canada.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.3.7.3. Canada: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.3.7.4. Canada: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.3.7.5. Canada: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • 10.4. AI in Genomics Market - Europe
    • 10.4.1. Europe: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
    • 10.4.2. Europe.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
    • 10.4.3. Europe: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
    • 10.4.4. Europe: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
    • 10.4.5. Europe: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.6. AI in Genomics Market - UK
      • 10.4.6.1. UK: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.6.2. UK.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.6.3. UK: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.6.4. UK: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.6.5. UK: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.7. AI in Genomics Market - France
      • 10.4.7.1. France: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.7.2. France.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.7.3. France: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.7.4. France: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.7.5. France: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.8. AI in Genomics Market - Germany
      • 10.4.8.1. Germany: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.8.2. Germany.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.8.3. Germany: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.8.4. Germany: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.8.5. Germany: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.9. AI in Genomics Market - Italy
      • 10.4.9.1. Italy: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.9.2. Italy.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.9.3. Italy: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.9.4. Italy: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.9.5. Italy: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.10. AI in Genomics Market - Spain
      • 10.4.10.1. Spain: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.10.2. Spain.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.10.3. Spain: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.10.4. Spain: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.10.5. Spain: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.11. AI in Genomics Market - Netherlands
      • 10.4.11.1. Netherlands: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.11.2. Netherlands.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.11.3. Netherlands: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.11.4. Netherlands: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.11.5. Netherlands: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.4.12. AI in Genomics Market - Russia
      • 10.4.12.1. Russia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.4.12.2. Russia.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.4.12.3. Russia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.4.12.4. Russia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.4.12.5. Russia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • 10.5. AI in Genomics Market - Asia Pacific
    • 10.5.1. Asia Pacific: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
    • 10.5.2. Asia Pacific.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
    • 10.5.3. Asia Pacific: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
    • 10.5.4. Asia Pacific: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
    • 10.5.5. Asia Pacific: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.5.6. AI in Genomics Market - China
      • 10.5.6.1. China: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.5.6.2. China.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.5.6.3. China: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.6.4. China: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.5.6.5. China: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.5.7. AI in Genomics Market - India
      • 10.5.7.1. India: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.5.7.2. India.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.5.7.3. India: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.7.4. India: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.5.7.5. India: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.5.8. AI in Genomics Market - Japan
      • 10.5.8.1. Japan: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.5.8.2. Japan.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.5.8.3. Japan: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.8.4. Japan: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.5.8.5. Japan: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.5.9. AI in Genomics Market - Malaysia
      • 10.5.9.1. Malaysia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.5.9.2. Malaysia.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.5.9.3. Malaysia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.9.4. Malaysia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.5.9.5. Malaysia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.5.10. AI in Genomics Market - Indonesia
      • 10.5.10.1. Indonesia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.5.10.2. Indonesia.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.5.10.3. Indonesia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.10.4. Indonesia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.5.10.5. Indonesia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.5.11. AI in Genomics Market - South Korea
      • 10.5.11.1. South Korea: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.5.11.2. South Korea.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.5.11.3. South Korea: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.5.11.4. South Korea: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.5.11.5. South Korea: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • 10.6. AI in Genomics Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
    • 10.6.2. Middle East & Africa: AI in Genomics Market, by Application, 2019-2032 (USD Million)
    • 10.6.3. Middle East & Africa: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
    • 10.6.4. Middle East & Africa: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
    • 10.6.5. Middle East & Africa: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.6.6. AI in Genomics Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.6.6.2. Saudi Arabia.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.6.6.3. Saudi Arabia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.6.6.4. Saudi Arabia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.6.6.5. Saudi Arabia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.6.7. AI in Genomics Market - UAE
      • 10.6.7.1. UAE: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.6.7.2. UAE.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.6.7.3. UAE: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.6.7.4. UAE: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.6.7.5. UAE: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.6.8. AI in Genomics Market - Israel
      • 10.6.8.1. Israel: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.6.8.2. Israel.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.6.8.3. Israel: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.6.8.4. Israel: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.6.8.5. Israel: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.6.9. AI in Genomics Market - South Africa
      • 10.6.9.1. South Africa: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.6.9.2. South Africa.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.6.9.3. South Africa: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.6.9.4. South Africa: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.6.9.5. South Africa: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • 10.7. AI in Genomics Market - Latin America
    • 10.7.1. Latin America: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
    • 10.7.2. Latin America.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
    • 10.7.3. Latin America: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
    • 10.7.4. Latin America: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
    • 10.7.5. Latin America: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.7.6. AI in Genomics Market - Mexico
      • 10.7.6.1. Mexico: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.7.6.2. Mexico.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.7.6.3. Mexico: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.7.6.4. Mexico: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.7.6.5. Mexico: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.7.7. AI in Genomics Market - Brazil
      • 10.7.7.1. Brazil: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.7.7.2. Brazil.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.7.7.3. Brazil: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.7.7.4. Brazil: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.7.7.5. Brazil: AI in Genomics Market, by End User, 2019-2032 (USD Million)
    • 10.7.8. AI in Genomics Market - Argentina
      • 10.7.8.1. Argentina: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
      • 10.7.8.2. Argentina.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
      • 10.7.8.3. Argentina: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
      • 10.7.8.4. Argentina: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
      • 10.7.8.5. Argentina: AI in Genomics Market, by End User, 2019-2032 (USD Million)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Google DeepMind
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. IBM Watson Health
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. BenevolentAI
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Tempus
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Freenome
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Sophia Genetics
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. 23andMe
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. DNAnexus
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Recursion Pharmaceuticals
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Verge Genomics
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. PathAI
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
  • 12.12. GNS Healthcare
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Recent Development
  • 12.13. Freenome
    • 12.13.1. Company Overview
    • 12.13.2. Financial Performance
    • 12.13.3. Product Benchmarking
    • 12.13.4. Recent Development
  • 12.14. Fabric Genomics
    • 12.14.1. Company Overview
    • 12.14.2. Financial Performance
    • 12.14.3. Product Benchmarking
    • 12.14.4. Recent Development
  • 12.15. Foundation Medicine
    • 12.15.1. Company Overview
    • 12.15.2. Financial Performance
    • 12.15.3. Product Benchmarking
    • 12.15.4. Recent Development
  • 12.16. SOPHiA GENETICS
    • 12.16.1. Company Overview
    • 12.16.2. Financial Performance
    • 12.16.3. Product Benchmarking
    • 12.16.4. Recent Development
  • 12.17. Nebula Genomics
    • 12.17.1. Company Overview
    • 12.17.2. Financial Performance
    • 12.17.3. Product Benchmarking
    • 12.17.4. Recent Development
  • 12.18. CytoReason
    • 12.18.1. Company Overview
    • 12.18.2. Financial Performance
    • 12.18.3. Product Benchmarking
    • 12.18.4. Recent Development
  • 12.19. Genoox
    • 12.19.1. Company Overview
    • 12.19.2. Financial Performance
    • 12.19.3. Product Benchmarking
    • 12.19.4. Recent Development
  • 12.20. Genalice
    • 12.20.1. Company Overview
    • 12.20.2. Financial Performance
    • 12.20.3. Product Benchmarking
    • 12.20.4. Recent Development
  • 12.21. Deep Genomics
    • 12.21.1. Company Overview
    • 12.21.2. Financial Performance
    • 12.21.3. Product Benchmarking
    • 12.21.4. Recent Development
  • 12.22. Owkin
    • 12.22.1. Company Overview
    • 12.22.2. Financial Performance
    • 12.22.3. Product Benchmarking
    • 12.22.4. Recent Development
  • 12.23. Genialis
    • 12.23.1. Company Overview
    • 12.23.2. Financial Performance
    • 12.23.3. Product Benchmarking
    • 12.23.4. Recent Development
  • 12.24. Gencove
    • 12.24.1. Company Overview
    • 12.24.2. Financial Performance
    • 12.24.3. Product Benchmarking
    • 12.24.4. Recent Development
  • 12.25. Helix
    • 12.25.1. Company Overview
    • 12.25.2. Financial Performance
    • 12.25.3. Product Benchmarking
    • 12.25.4. Recent Development
  • 12.26. QIAGEN Bioinformatics
    • 12.26.1. Company Overview
    • 12.26.2. Financial Performance
    • 12.26.3. Product Benchmarking
    • 12.26.4. Recent Development
  • 12.27. SOPHiA DDM
    • 12.27.1. Company Overview
    • 12.27.2. Financial Performance
    • 12.27.3. Product Benchmarking
    • 12.27.4. Recent Development
  • 12.28. WuXi NextCODE
    • 12.28.1. Company Overview
    • 12.28.2. Financial Performance
    • 12.28.3. Product Benchmarking
    • 12.28.4. Recent Development
  • 12.29. Genuity Science
    • 12.29.1. Company Overview
    • 12.29.2. Financial Performance
    • 12.29.3. Product Benchmarking
    • 12.29.4. Recent Development
  • 12.30. Lifebit
    • 12.30.1. Company Overview
    • 12.30.2. Financial Performance
    • 12.30.3. Product Benchmarking
    • 12.30.4. Recent Development
  • 12.31. Envisagenics
    • 12.31.1. Company Overview
    • 12.31.2. Financial Performance
    • 12.31.3. Product Benchmarking
    • 12.31.4. Recent Development
  • 12.32. ZS Genetics
    • 12.32.1. Company Overview
    • 12.32.2. Financial Performance
    • 12.32.3. Product Benchmarking
    • 12.32.4. Recent Development
  • 12.33. MedGenome
    • 12.33.1. Company Overview
    • 12.33.2. Financial Performance
    • 12.33.3. Product Benchmarking
    • 12.33.4. Recent Development
  • 12.34. Cypher Genomics
    • 12.34.1. Company Overview
    • 12.34.2. Financial Performance
    • 12.34.3. Product Benchmarking
    • 12.34.4. Recent Development
  • 12.35. PierianDx
    • 12.35.1. Company Overview
    • 12.35.2. Financial Performance
    • 12.35.3. Product Benchmarking
    • 12.35.4. Recent Development
  • 12.36. Bluebee
    • 12.36.1. Company Overview
    • 12.36.2. Financial Performance
    • 12.36.3. Product Benchmarking
    • 12.36.4. Recent Development
  • 12.37. Repositive
    • 12.37.1. Company Overview
    • 12.37.2. Financial Performance
    • 12.37.3. Product Benchmarking
    • 12.37.4. Recent Development
  • 12.38. Precision for Medicine
    • 12.38.1. Company Overview
    • 12.38.2. Financial Performance
    • 12.38.3. Product Benchmarking
    • 12.38.4. Recent Development
  • 12.39. Shivom
    • 12.39.1. Company Overview
    • 12.39.2. Financial Performance
    • 12.39.3. Product Benchmarking
    • 12.39.4. Recent Development
  • 12.40. Bluegnome
    • 12.40.1. Company Overview
    • 12.40.2. Financial Performance
    • 12.40.3. Product Benchmarking
    • 12.40.4. Recent Development

List of Tables

  • Table 1 Global AI in Genomics Market, by Offering, by Region, 2019-2032 (USD Million)
  • Table 2 Global AI in Genomics Market, by Technology, by Region, 2019-2032 (USD Million)
  • Table 3 Global AI in Genomics Market, by Functionality, by Region, 2019-2032 (USD Million)
  • Table 4 Global AI in Genomics Market, by End User, by Region, 2019-2032 (USD Million)
  • Table 5 Global AI in Genomics Market, by Application, by Region, 2019-2032 (USD Million)
  • Table 6 North America: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 7 North America: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 8 North America: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 9 North America: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 10 North America: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 11 U.S.: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 12 U.S.: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 13 U.S.: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 14 U.S.: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 15 U.S.: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 16 Canada: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 17 Canada: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 18 Canada: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 19 Canada: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 20 Canada: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 21 Europe: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 22 Europe: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 23 Europe: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 24 Europe: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 25 Europe: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 26 Germany: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 27 Germany: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 28 Germany: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 29 Germany: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 30 Germany: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 31 France: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 32 France: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 33 France: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 34 France: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 35 France: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 36 UK: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 37 UK: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 38 UK: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 39 UK: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 40 UK: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 41 Italy: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 42 Italy: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 43 Italy: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 44 Italy: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 45 Italy: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 46 Netherlands: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 47 Netherlands: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 48 Netherlands: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 49 Netherlands: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 50 Netherlands: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 51 Spain: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 52 Spain: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 53 Spain: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 54 Spain: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 55 Spain: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 56 Russia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 57 Russia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 58 Russia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 59 Russia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 60 Russia: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 61 Asia Pacific: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 62 Asia Pacific: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 63 Asia Pacific: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 64 Asia Pacific: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 65 Asia Pacific: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 66 China: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 67 China: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 68 China: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 69 China: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 70 China: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 71 Japan: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 72 Japan: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 73 Japan: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 74 Japan: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 75 Japan: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 76 India: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 77 India: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 78 India: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 79 India: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 80 India: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 81 Indonesia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 82 Indonesia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 83 Indonesia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 84 Indonesia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 85 Indonesia: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 86 Malaysia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 87 Malaysia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 88 Malaysia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 89 Malaysia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 90 Malaysia: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 91 South Korea: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 92 South Korea: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 93 South Korea: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 94 South Korea: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 95 South Korea: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 96 Latin America: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 97 Latin America: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 98 Latin America: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 99 Latin America: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 100 Latin America: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 101 Brazil: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 102 Brazil: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 103 Brazil: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 104 Brazil: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 105 Brazil: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 106 Mexico: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 107 Mexico: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 108 Mexico: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 109 Mexico: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 110 Mexico: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 111 Argentina: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 112 Argentina: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 113 Argentina: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 114 Argentina: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 115 Argentina: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 116 Middle East & Africa: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 117 Middle East & Africa: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 118 Middle East & Africa: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 119 Middle East & Africa: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 120 Middle East & Africa: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 121 UAE: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 122 UAE: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 123 UAE: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 124 UAE: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 125 UAE: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 126 Saudi Arabia: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 127 Saudi Arabia: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 128 Saudi Arabia: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 129 Saudi Arabia: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 130 Saudi Arabia: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 131 South Africa: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 132 South Africa: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 133 South Africa: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 134 South Africa: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 135 South Africa: AI in Genomics Market, by Application, 2019-2032 (USD Million)
  • Table 136 Israel: AI in Genomics Market, by Offering, 2019-2032 (USD Million)
  • Table 137 Israel: AI in Genomics Market, by Technology, 2019-2032 (USD Million)
  • Table 138 Israel: AI in Genomics Market, by Functionality, 2019-2032 (USD Million)
  • Table 139 Israel: AI in Genomics Market, by End User, 2019-2032 (USD Million)
  • Table 140 Israel: AI in Genomics Market, by Application, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global AI in Genomics Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Offering
  • Figure 7. Global AI in Genomics Market, by Offering, 2021 & 2030 (USD Million)
  • Figure 8. Market by Technology
  • Figure 9. Global AI in Genomics Market, by Technology, 2021 & 2030 (USD Million)
  • Figure 10. Market by Functionality
  • Figure 11. Global AI in Genomics Market, by Functionality, 2021 & 2030 (USD Million)
  • Figure 12. Market by End User
  • Figure 13. Global AI in Genomics Market, by End User, 2021 & 2030 (USD Million)
  • Figure 14. Market by Application
  • Figure 15. Global AI in Genomics Market, by Application, 2021 & 2030 (USD Million)